Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes - Wikidata - awgldk - TriplyDB

Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes

Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes

http://www.wikidata.org/entity/Q22306079

about

Beclometasone for chronic obstructive pulmonary disease Beclometasone for COPD Inhaled corticosteroids for stable chronic obstructive pulmonary disease Inhaled corticosteroids for stable chronic obstructive pulmonary disease Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease Efficacy and safety of inhaler steroids in COPD patients: Systematic review and meta-analysis of randomized placebo-controlled trials Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic review Copd.Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.Nebulized corticosteroids in the management of acute exacerbation of COPD.Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.Prevalence of inappropriate prescribing of inhaled corticosteroids for respiratory tract infections in the Netherlands: a retrospective cohort study Determinants of spirometry use and accuracy of COPD diagnosis in primary care Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials.Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbation Optimizing safety of COPD treatments: role of the nurse practitioner.Inhaled therapy for stable chronic obstructive pulmonary disease.Assessing treatment effects of inhaled corticosteroids on medical expenses and exacerbations among COPD patients: longitudinal analysis of managed care claims.Future therapeutic treatment of COPD: struggle between oxidants and cytokines Treating COPD with PDE 4 inhibitors.Chronic airflow limitation in developing countries: burden and priorities.Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study.Targeting lung inflammation: novel therapies for the treatment of COPD.Mortality in COPD: causes, risk factors, and prevention.Updates in the management of stable chronic obstructive pulmonary disease.Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review.The evaluation of general practitioners' awareness/knowledge and adherence to the GOLD guidelines in a Shanghai suburb.On TRACK: medical research must consider context and complexity.Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.Medication use patterns associated with spirometry in diagnosing COPD.In This Issue: Communication in the Era of ’Personalized‘ Medicine.

P2860

Q24197535-AEFBC2AE-CEAC-48B9-B24C-7DB8AACECD04 Q24200572-025EC7A5-A611-401A-ADCC-0C5827268433 Q24202092-E5CD4BCE-670E-4480-B62A-F5746F46E48E Q24245481-4C3B2B13-5AF1-4F0A-8649-CAD8B0D4A60C Q26741051-F5575917-2624-4BC0-85B6-109E33571278 Q27025647-6CF58B12-1074-4ACC-8CCB-186F88939B9B Q28069762-684E59FD-B8F7-49A7-985D-C2C289673D3C Q31016356-0A6AC848-AA99-4E39-AD26-5ECF7C942AE8 Q34065276-91A60D1A-E50D-41B7-85C0-4BB140D65E51 Q34332863-D28470A7-AE40-4D57-BB40-BB1A56D2372E Q34888769-E22FF0DC-0317-4F84-B5D5-3C663D0D39CD Q35216460-701E63B5-B0AC-4197-A65F-F054C59685E5 Q35527052-B2B88657-827E-4B10-B582-1F48184F5925 Q35747045-5691D291-D31E-4FCB-881B-D8E668EAB054 Q36526988-2DB196E5-4724-40F7-BB44-1F5A65736D7D Q36642198-DFD8FFE5-5E1D-4A39-8461-E250A7BEBE50 Q36787296-7175D6BC-ACD6-4FB9-AC86-C4FDCF5FF68D Q37037387-BA93329B-0C66-45C7-B363-9E604E199CDE Q37071004-22103D87-5DEB-49FC-B91B-D5C76D436E1C Q37082594-9AB1E855-57D8-44A6-8B1E-B140B27AF01C Q37225477-47955BDB-46ED-4ACB-BDD5-BA21D884DA14 Q37412958-332CDF4E-B2B5-4731-85A8-B8D5A2F7BB62 Q37412962-38E1E877-26D1-44D8-82AA-CF2259952021 Q37578310-3F9FEBDC-4DFB-48A1-9BEA-7E8F878EB3AA Q37790366-30704EBA-CE00-4A25-BA9F-36E000FAD266 Q38578596-3DCB1C66-4F29-41B7-A00E-CC4410AEE3BE Q38621360-62655E3F-E5DE-4D85-B715-E99D1285DE5A Q38827675-091351FF-84F7-40F0-AEE7-04BFDEE0DAD6 Q40093103-C50CA287-893C-4933-B03D-AE47443A7619 Q41993638-F4DAC3BE-E5B6-4947-A7AA-1964AA6023CA Q45917632-7488F2D5-DA9D-42DB-8DC8-C8A14F2B2363 Q46057466-BA85DCE8-89AC-4856-8EA5-EF13370DB671 Q55554861-F7AA6BB2-52A0-4216-81A5-0565C037C9E1

P2860

Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes

http://www.wikidata.org/entity/Q22306079

description

2006 nî lūn-bûn

@nan

2006 թուականին հրատարակուած գիտական յօդուած

@hyw

2006 թվականին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Efficacy and safety of inhaled ...... ta-analysis of health outcomes

@ast

Efficacy and safety of inhaled ...... ta-analysis of health outcomes

@en

Efficacy and safety of inhaled ...... ta-analysis of health outcomes

@en-gb

Efficacy and safety of inhaled ...... ta-analysis of health outcomes

@nl

type

label

Efficacy and safety of inhaled ...... ta-analysis of health outcomes

@ast

Efficacy and safety of inhaled ...... ta-analysis of health outcomes

@en

Efficacy and safety of inhaled ...... ta-analysis of health outcomes

@en-gb

Efficacy and safety of inhaled ...... ta-analysis of health outcomes

@nl

prefLabel

Efficacy and safety of inhaled ...... ta-analysis of health outcomes

@ast

Efficacy and safety of inhaled ...... ta-analysis of health outcomes

@en

Efficacy and safety of inhaled ...... ta-analysis of health outcomes

@en-gb

Efficacy and safety of inhaled ...... ta-analysis of health outcomes

@nl

P1433

Q22306079-3F52ADDC-9972-4F71-BE52-79C7238A3B8E

P1476

Q22306079-C302762E-2FD6-4FDF-89B6-3A2129D98DE6

P2093

Q22306079-A16AF9A6-A97A-4666-A577-EC4B4A0874AA

Q22306079-B425FC9B-CD01-4013-969C-EECA63C1DEE4

P2860

Q22306079-0D0D2391-DA3F-4FF7-813A-40697859776F

Q22306079-10483BA9-C6A9-4EEB-A70F-CB6B33DB2831

Q22306079-146377A4-80A0-43E8-B2F4-0F2E63E8FD5D

Q22306079-2403C860-2DB0-4144-82F1-CDC29D58D1DF

Q22306079-277FCB33-23A6-4F4B-95D6-BAB940C20473

Q22306079-3595769A-23EE-45BB-B0D9-A3B8A50AF6FF

Q22306079-363C62A6-9890-4859-88FF-89E2F160A7E2

Q22306079-370B50E0-938B-436C-AA4F-B8C758243C87

Q22306079-3B731266-8A36-4DE6-8D07-D65CB2C70EB1

Q22306079-3D6B84DC-0A23-4563-AD73-5006E376C058

P304

Q22306079-2C01C5FF-2A0A-461B-80BC-7D79E024AA08

P31

Q22306079-0456EDB9-1ACC-4C9B-A2DB-39D3D6C10BF1

Q22306079-067C3FAB-6DB0-40E4-94C1-6712F84A4CA7

Q22306079-6E2B5B1C-1875-4F7D-8C4E-C84AC6872ECA

P3181

Q22306079-1415FFBD-1366-4F5A-8D0E-6C65E5F1A14F

P356

Q22306079-E730B138-3A4E-4AAD-9A74-A3CC936F44EB

P407

Q22306079-E6A6C2F3-8E70-4F1E-B641-F9DF0ABE167B

P433

Q22306079-DEDBFD9D-A9EA-4237-88C2-078243AACABE

P478

Q22306079-F3CF5D95-A20B-4179-A254-A128F2959C25

P50

Q22306079-7762AB72-461E-49CD-9D93-7454F4289E4F

Q22306079-CAC07A23-25D7-41A8-9E4C-62E63501E61E

P577

Q22306079-0AD02F84-6BDA-4C02-9FF4-BDC81CEF9C6C

P5875

Q22306079-83506AA2-F214-49DE-9217-4C2E7BD8CA03

P698

Q22306079-A8E1CAEC-7780-422F-A817-21A8712FE2B8

P921

Q22306079-5D2E5E64-4C4F-4FE1-8954-DB50D9470BE6

Q22306079-B7C298AC-7B5C-4631-A8D4-38206AE05432

Q22306079-F8EDB917-B1C4-41CF-9952-2906C8C60361

P932

Q22306079-63088BA0-0CBA-4E2C-86FD-9B0883D92C3C

P3181

P356

P1433

Annals of Family Medicine

P1476

Efficacy and safety of inhaled ...... ta-analysis of health outcomes

@en

P2093

Kathleen N Lohr

http://www.w3.org/2001/XMLSchema#string

Shannon S Carson

http://www.w3.org/2001/XMLSchema#string

P2860

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

Inhaled corticosteroids, family history, and risk of glaucoma.

The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials

Current methods of the US Preventive Services Task Force: a review of the process.

Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease.

Impact of preventing exacerbations on deterioration of health status in COPD.

Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma.

Dose response and therapeutic index of inhaled corticosteroids in asthma.

P304

253-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

2626417

http://www.w3.org/2001/XMLSchema#string

P356

10.1370/AFM.517

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Gerald Gartlehner

Richard A. Hansen

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7046416

http://www.w3.org/2001/XMLSchema#string

P698

16735528

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

1479432

http://www.w3.org/2001/XMLSchema#string